Report Publication Announcement • Feb 15, 2016
Report Publication Announcement
Open in ViewerOpens in native device viewer
Invitation Stockholm 15 February 2016
In connection with this, a conference call for investors, analysts and media will be held at 10:00 CET on February 18. CEO Christian Kinch and CFO Fredrik Järrsten will present the report and answer questions.
The year end report will be available at Bactiguard's website www.bactiguard.com from 08:00 CET the same day.
Ulrika Berglund, Head of External Affairs, mobile: +46 708 80 04 07
Susann Remnert, Communication Manager, mobile: +46 709 195 342 e-mail: [email protected]
Bactiguard is a Swedish medtech company with a global presence, offering a solution that prevents healthcare associated infections caused by medical devices. By preventing infections, we contribute to a reduced use of antibiotics and the spread of multi-resistant bacteria, which is a growing problem worldwide. We save lives, increase patient safety and significantly reduce the cost for the healthcare and society. Our technology is well-proven, safe and tissue friendly and consist of a thin layer of noble metals that prevents bacterial growth. The coating can be applied on almost all medical devices. Bactiguard-coated urinary catheters are market leading in the US and Japan and the company has also its own product portfolio consisting of Foley catheters, central venous catheters and endotracheal tubes. Bactiguard is a growth company, focused on markets in Europe, Middle East, Asia and Latin America. The company has about 70 employees worldwide, mainly at the headquarters in Stockholm and the production facility in Malaysia and is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.